Process for production of stabilized powdery secretin preparation by lyophilization
AssigneeEisai Co., Ltd.
InventorsEiichi Suenaga, Shinro Tachibana, Nagayasu Sato
Life of this patent
Estimating the term…
Loading patent…
AssigneeEisai Co., Ltd.
InventorsEiichi Suenaga, Shinro Tachibana, Nagayasu Sato
Estimating the term…
Stabilized powdery secretin preparation wherein secretin is carried on an adequate amount of alanine serving as excipient and weighing material, which is produced by lyophilization of an aqueous solution of secretin in the presence of alanine, the product being useful for therapeutic treatment of diseases and for diagnosis of disorders in digestive tracts such as pancreas and gallbladder.
A process for producing a stabilized powdery secretin preparation which comprises lyophilizing an aqueous solution of secretin having a pH of 4-7 in the presence of a 2-10% aqueous solution of alanine as carrier for the secretin.
A pharmaceutical composition consisting essentially of a minor proportion of secretin and a major proportion of a member selected from the group consisting of .alpha.-alanine, .beta.-alanine and mixtures thereof as carrier therefor.
A pharmaceutical composition consisting essentially of a minor proportion of secretin, a member selected from the group consisting of .alpha.-alanine, .beta.-alanine and mixtures thereof as carrier therefor and a buffer selected from the group consisting of tartaric acid, phosphoric acid, succinic acid and citric acid in an amount sufficient to impart a pH of 4-7 to an aqueous solution of said composition.
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
No related US applications are recorded in the indexed filing history.
No references of this kind are recorded.
Hormones: secretins
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles: lyophilised , i.e.…
Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids: amino acids, e.g. glycine, EDTA or…
Medicines and medical preparations
Term ended 24 Feb 1993 (estimated)
USPTO file history isn’t available for this patent, so only indexed dates are shown.
This invention relates to a stabilized powdery secretin preparation and a process for the production thereof. More particularly, the invention relates to a stabilized powdery secretin preparation useful for therapeutic treatment, wherein the secretin is carried on an adequate amount of alanine serving as excipient and weighing material, and a process for the production thereof by lyophilization of an aqueous solution of secretin in the presence of the alanine.
Secretin is one of the hormones present in digestive tracts and capable of stimulating excretion of enzyme-free pancreatic juice from pancreas and inhibiting gastrine-stimulated gastric secretion. Secretin is therefore useful for therapeutic treatment of diseases in digestive tracts and for diagnosis of disorders thereof.
Secretin as is known is so unstable that it gradually loses its hormone activity even if kept at a low temperature such as -20.degree.C. Addition of cysteine hydrochloride to secretin was proposed in order to improve its temperature stability and a certain increase in its stability was thus attained. It was found however that the stabilized secretin preparation is still unstable and cannot stand for a prolonged period of storage at room temperature. It is thus necessary to keep the preparation in a refrigerator.
An aqueous solution was prepared by dissolving under sterilization 2 grams of .alpha.-alanine and 5000 Crick, Harper and Raper units of secretin into 50 ml of a buffer solution of pH 4.5 containing 0.03 M citric and phosphoric acids. Each 0.5 ml aliquot of the resulting solution was lyophilized in an ampoule of 2 ml capacity and then sealed.
An aqueous solution was prepared by dissolving under sterilization 3 grams of .beta.-alanine and 5000 Crick, Harper and Raper units of secretin into 50 ml of a 0.02 M tartaric acid buffer solution of pH 4.5. Each 0.5 ml aliquot of the resulting solution was lyophilized in an ampoule of 2 ml capacity and then sealed.
An aqueous solution was prepared by dissolving under sterilization 1 gram of .alpha.-alanine, 1 gram of .beta.-alanine and 5000 Crick, Harper and Raper units of secretin into 50 ml of a 0.02 M citric acid buffer solution at pH 5.0. Each 0.5 ml aliquot of the resulting solution was lyophilized in an ampoule of 2 ml capacity and then sealed.